Literature DB >> 8217828

Vitamin K metabolism and vitamin K1 status in human liver samples: a search for inter-individual differences in warfarin sensitivity.

H H Thijssen1, M J Drittij-Reijnders.   

Abstract

Vitamin K-dependent parameters in human liver samples were investigated to find a clue to the inter-individual differences in sensitivity for oral anticoagulants. Vitamin K epoxide reductase and vitamin K-dependent carboxylase activity differed 2-3-fold between the samples. Microsomal warfarin binding correlated significantly with the reductase activity. Microsomal vitamin K epoxide reductase of the different samples showed equal sensitivity for warfarin inhibition, I50 about 0.1 microM. Vitamin K epoxide reductase activity stimulated by NADH/lipoamide and microsomal lipoamide dehydrogenase activity showed higher inter-subject variability than the reductase activity by itself. Liver vitamin K1 levels varied 4-5-fold. Total and liver microsomal vitamin K1 levels were correlated. One of the liver samples was obtained from a donor anticoagulated with phenprocoumon and additionally treated with vitamin K1. High levels of the vitamin and its epoxide were present. Phenprocoumon was essentially irreversibly bound to the microsomes. In general the results confirm inter-individual differences in the hepatic vitamin K-dependent systems; the differences as such were found to be small. However, as the various parameters can work synergistically in the same direction, they may well account for the wide dose range observed in oral anticoagulant therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8217828     DOI: 10.1111/j.1365-2141.1993.tb03146.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Microsomal lipoamide reductase provides vitamin K epoxide reductase with reducing equivalents.

Authors:  H H Thijssen; Y P Janssen; L T Vervoort
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

Review 2.  Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.

Authors:  G Palareti; C Legnani
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

3.  Ethnic differences in the population pharmacokinetics and pharmacodynamics of warfarin.

Authors:  Eunice Yuen; Ivelina Gueorguieva; Stephen Wise; Danny Soon; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-11-26       Impact factor: 2.745

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.